Page: Maximum residue limit (MRL) evaluation for biological substances - Scientific guideline-2024/1/26

Document: Procedural advice for orphan medicinal product designation: Guidance for sponsors-2025/1/30

Document: List of withdrawn medicinal products in accordance with Art. 123(4) of the Directive (1 January - 31 December 2024)-2025/3/7

Document: Minutes of the PRAC meeting 25-28 November 2024-2025/4/9

Page: COVID-19 vaccines: key facts-2025/5/21

Document: Call for comments on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)-2025/6/27

Page: Emtricitabine/tenofovir disoproxil product-specific bioequivalence guidance-2025/7/30

Document: UPD registration guide for UI and API users-2025/9/17

Document: Overview of (invented) names reviewed in September 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 16 October 2025-2025/10/23

Document: Meeting report - EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins-2025/11/25